CAS 53858-86-9

Ferric hydroxide polymaltose complex

Description:

Ferric hydroxide polymaltose complex is an iron supplement commonly used to treat iron deficiency anemia. This complex consists of ferric hydroxide, which is a form of iron, combined with polymaltose, a carbohydrate that enhances the stability and bioavailability of iron. The complex is characterized by its ability to provide a controlled release of iron, minimizing gastrointestinal side effects often associated with traditional iron supplements. It is typically administered orally and is known for its relatively good tolerability. The complex is also less likely to cause oxidative stress compared to other iron formulations. In terms of its chemical properties, it is generally a brownish powder, insoluble in water but can be dispersed in aqueous solutions. The formulation is designed to improve iron absorption in the intestines while reducing the risk of interactions with other dietary components. Overall, ferric hydroxide polymaltose complex is a valuable therapeutic option for individuals requiring iron supplementation.

Formula: Unspecified

Synonyms:

• Ferrum Hausmann i.m.
• Amylofer
• Ferrum Hausmann oral
• Ferric hydroxide polymaltose complex
• Maltofer

Iron Polymaltose (Ferric Carboxymaltose)

CAS: 53858-86-9

Color and Shape: Reddish Brown Solid

Ref: 4Z-I-121001

Ferric Carboxymaltose (Technical Grade)

Controlled Product

CAS: 53858-86-9

Applications Ferric Carboxymaltose is used to treat iron deficiency anaemia.
References Tan, Michelle Li Nien, et al.: Euro. J. of Ped., 176(10), 1419-1423 (2017);Macher, Susanne, et al.: Trials, 17, 527/1-527/7 (2016)

Formula: C₄H₂N₂OBr₂

Color and Shape: Dark Red To Dark Brown

Ref: TR-F307530

Ferric carboxymaltose

CAS: 53858-86-9

Ferric carboxymaltose is a form of iron that is administered intravenously and is used to treat iron deficiency. Ferric carboxymaltose has been shown to be effective in treating iron deficiency anemia as well as other conditions, such as inflammation of the bowel or hematologic response. Ferric carboxymaltose binds to free iron in the blood and prevents it from oxidizing. Ferric carboxymaltose also exhibits an anti-inflammatory effect by inhibiting the production of pro-inflammatory cytokines and chemokines. The polymerase chain reaction (PCR) technique has been used to measure ferritin levels in the blood, which are then used to determine whether treatment with ferric carboxymaltose is necessary.

Color and Shape: Powder

Ref: 3D-MF167728